877-202-0205     support@chemchart.com     @chemchart
        
Sign In    Register
   Reset Filters

Psychopharmacology, Drugs for benign prostatic hyperplasia

Categories

Alpha blockers (11)
Antihypertensive agents (11)
Drugs acting on the cardiovascular system (11)
Drugs acting on the genito-urinary system (11)
Drugs acting on the nervous system (11)
Psychoactive drugs (11)
Urologicals (11)
Pharmaceuticals (8)
Antihistamines (7)
Alpha-2 blockers (6)
Antidepressants (6)
Antipsychotics (6)
Dopamine antagonists (6)
H1 receptor antagonists (6)
Aromatic compounds (5)
Cyclic compounds (5)
Alpha-1 blockers (4)
Nervous system drug (4)
Six-membered rings (4)
Tetracyclic antidepressants (4)
Atypical antipsychotics (3)
D2 antagonists (3)
Fluoroarenes (3)
Noradrenergic and specific serotonergic antidepressants (3)
Organic compound (3)
Piperidines (3)
Chloroarenes (2)
D3 antagonists (2)
Psychoanaleptics (2)
Typical antipsychotics (2)
Antiparkinsonian agents (1)
Anxiolytics (1)
Aromatic ketones (1)
D2-receptor agonists (1)
D3 receptor agonists (1)
D4 antagonists (1)
Dopamine agonists (1)
Five-membered rings (1)
Imidazolines (1)
Mood stabilizers (1)
Piperazines (1)
Psycholeptics (1)

Suppliers

Sigma Aldrich (4)
Toronto Research Chemicals (3)
TCI Chemicals (3)
AK Scientific (2)
Matrix Scientific (2)
Accela (1)
Oakwood Chemical (1)

Aripiprazole (129722-12-9)  
Aripiprazole, sold under the brand name Abilify among others, is an atypical antipsychotic. From April 2013 to March 2014, sales of Abilify amounted to almost $6.9 billion.. It is recommended by some doctors and used in the treatment of schizophrenia and bipolar disorder.
Risperidone (106266-06-2)  
Risperidone, sold under the trade name Risperdal among others, is an antipsychotic medication. It is mainly used to treat schizophrenia, bipolar disorder, and irritability in people with autism. It is taken either by mouth or by injection into a muscle.
mirtazapine (61337-67-5, 85650-52-8)  
Remeron  ·  Rexer  ·  ORG 3770
Mirtazapine, sold under the brand name Remeron among others, is an atypical antidepressant which is used primarily in the treatment of depression. In addition to its antidepressant properties, mirtazapine has anxiolytic, sedative, antiemetic, and appetite stimulant effects and is sometimes used in the treatment of anxiety disorders, insomnia, nausea and vomiting, and to produce weight gain when desirable. It is taken by mouth.
Esmirtazapine (61337-87-9)  
mirtazapine  ·  Remeron  ·  Rexer
Esmirtazapine (ORG-50,081) is a drug which was under development by Organon for the treatment of insomnia and vasomotor symptoms (e.g., hot flashes) associated with menopause. Esmirtazapine is the (S)-(+)-enantiomer of mirtazapine and possesses similar overall pharmacology, including inverse agonist actions at H1 and 5-HT2 receptors and antagonist actions at α2-adrenergic receptors. As of March 2010, Merck terminated internal clinical development program for esmirtazapine, for hot flashes and insomnia, for strategic reasons.
Pipamperone (1893-33-0)  
R 3345  ·  Dipiperon  ·  1'-(3-(4-fluorobenzoyl)propyl)-(1,4'-bipiperidine) -4'-carboxamide
Pipamperone (INN, USAN, BAN), also known as carpiperone and floropipamide or fluoropipamide, and as floropipamide hydrochloride (JAN), is a typical antipsychotic of the butyrophenone family used in the treatment of schizophrenia. It is or has been marketed under brand names including Dipiperon, Dipiperal, Piperonil, Piperonyl, and Propitan. Pipamperone was discovered at Janssen Pharmaceutica in 1961, and entered clinical trials in the United States in 1963.
MELPERONE (3575-80-2)  
Melperone (Bunil (PT), Buronil (AT, BE, CZ, DK, FL†, NL†, NO†, SE), Eunerpan (DE)) is an atypical antipsychotic of the butyrophenone chemical class, making it structurally related to the typical antipsychotic haloperidol. It first entered clinical use in 1960s.
Cyamemazine (3546-03-0)  
cyamamazine  ·  10-(3-dimethylamino-2-methylpropyl)phenothiazine-2-carbonitrile  ·  cyamepromazine
Cyamemazine (Tercian), also known as cyamepromazine, is a typical antipsychotic drug of the phenothiazine class which was introduced by Theraplix in France in 1972 and later in Portugal as well. It is used for the treatment of schizophrenia and, especially, for psychosis-associated anxiety, due to its unique anxiolytic efficacy. Cyamemazine differs from other phenothiazine neuroleptics in that aside from the usual profile of dopamine, α1-adrenergic, H1, and mACh receptor antagonism, it additionally produces potent blockade of several serotonin receptors, including 5-HT2A, 5-HT2C, and 5-HT7.
BENZOCTAMINE (17243-39-9)  
Benzoctamine is a drug that possesses sedative and anxiolytic properties. Marketed as Tacitin by Ciba-Geigy, it is different from most sedative drugs because in most clinical trials it does not produce respiratory depression, but actually stimulates the respiratory system. As a result, when compared to other sedative and anxiolytic drugs such as benzodiazepines like diazepam, it is a safer form of tranquilizing.
Ocaperidone (129029-23-8)  
Ocaperidone (also R 79598) is a benzisoxazole antipsychotic. It was initially developed by Janssen, later licensed to French laboratory Neuro3D and then acquired in 2007 by German company Evotec. Its testing was abandoned after phase II trials, as of 22 February 2010.
FENMETOZOLE (41473-09-0)  
Fenmetozole (DH-524) is a drug which was patented as an antidepressant, but was later studied as an antagonist of the effects of ethanol, though results were poor and it even increased its effects in some cases. It acts as an α2-adrenergic receptor antagonist similarly to other imidazoles like idazoxan. It was never marketed.
Related searches
Psychopharmacology
Drugs for benign prostatic hyperplasia